Live Breaking News & Updates on Study results

Stay informed with the latest breaking news from Study results on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Study results and stay connected to the pulse of your community

Ocugen to Present on Modifier Gene Therapy Platform at

MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...

Nieraj-jain , Arun-upadhyay , Joses-pulido , Murthy-chavali , Shankar-musunuri , Borooah-shyamanga , Benjamin-bakall , Arunk-upadhyay , Nalin-mehta , Sahar-matloob , Paul-yang

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Shankar-musunuri , Murthy-chavali , Benjamin-bakall , Borooah-shyamanga , Arunk-upadhyay , Paul-yang , Nalin-mehta , Sahar-matloob , Arun-upadhyay , Nieraj-jain , Joses-pulido

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Murthy-chavali , Benjamin-bakall , Arun-upadhyay , Joses-pulido , Borooah-shyamanga , Arunk-upadhyay , Sahar-matloob , Shankar-musunuri , Paul-yang , Nieraj-jain , Nalin-mehta

Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome

– Phase 1/2a End of Study Data: 70mg doses demonstrated substantial and sustained reductions in convulsive seizure frequency on top of the best available anti-seizure medicines; Median reductions...

United-kingdom , United-states , Ukraine , Bedford , Massachusetts , Cambridge , Cambridgeshire , Edwardm-kaye , Joseph-sullivan , Drug-administration , Company-annual-report-on-form , Nasdaq

Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome

Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bedford , Massachusetts , United-states , Ukraine , United-kingdom , Cambridge , Cambridgeshire , Joseph-sullivan , Edwardm-kaye , Eric-rojas , Exchange-commission , Augmentation-of-nuclear-gene-output

Cannabis Prohibition Linked to 90% More Delta 8 THC Searches, According to CBD Nationwide's Latest Research

/PRNewswire/ -- CBD Nationwide's latest study reveals a 90% spike in Delta 8 THC searches in states banning recreational cannabis, highlighting the significant...

Katie-devoe , Nationwide-trends-discovers , Direct-correlation-between-cannabis-bans , Increased-searches , Google-trends , Cannabis-alternatives , Policy-implications , Study-results , Cbd-nationwide ,

ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024

ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Madrid , Spain , Boston , Massachusetts , Barcelona , Comunidad-autonoma-de-cataluna , American , I-sant-pau , Sarah-fineberg

New Clinical Trial Demonstrates That Qualia Senolytic Decreases Joint Discomfort*

New Clinical Trial Demonstrates That Qualia Senolytic Decreases Joint Discomfort*
bubblear.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bubblear.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , New-zealand , United-states , Australia , America , Qualia-senolytic , Improvement-in-joint-health-performance , Drug-administration , Neurohacker-collective , Western-ontario , Mcmaster-universities-osteoarthritis-index , Joint-health